~~<i id='1DC516ED08'><strike id='1DC516ED08'><tt id='1DC516ED08'><pre id='1DC516ED08'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：Wikipedia 2025-10-02 06:02:19 - browse：95

A sign of AdventHealth on its building in Orlando, Florida — coverage from STAT — Adobe

A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.”

The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.

The new, highly detailed legal filings also come right as MultiPlan and more than a dozen of the largest tax-exempt, nonprofit hospital systems are wooing investors at the J.P. Morgan Healthcare Conference. AdventHealth did not attend this year’s conference, but did so last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

leisure time

hotspot

Wikipedia

knowledge

AdobeResearchuniversitiesarevoicingconcernsoversomeproposedchangestotheprocessforreviewingscientific

WSS

Why doctors need education on FDA device approval process

Chemotherapy shortages won’t get better under Biden’s latest plan

Chemotherapy shortages won’t get better under Biden’s latest plan

After sickle

How digital therapeutics firms are pivoting after Pear's bankruptcy

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

explore

leisure time

leisure time

Drug repurposing or repositioning? The language matters

Chemotherapy shortages won’t get better under Biden’s latest plan

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pfizer plans to depart BIO

Drug repurposing or repositioning? The language matters

Teach medical students about patients with intellectual disabilities

Wildfire smoke exposes gaps in outdoor worker protections

Pharma patents targeted by Biden in move to slash drug prices

ChatGPT in medicine: STAT answers readers' burning questions

FDA needs staff influx to meet gene therapy needs, Marks says

hotspot

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

The woman behind the Dana Farber

FDA needs staff influx to meet gene therapy needs, Marks says

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

FDA clears AI tool for detecting skin cancer

hotspot

hotspot

Wikipedia

knowledge